Education
About Us
Working with TipRanks
Follow Us
Bruce Carter Insider Profile
4 Followers
Bruce Carter, Director at Enanta Pharmaceuticals, holds 0.00 shares in Mirati Therapeutics (Ticker: MRTX), holds 0.00 shares in Enanta Pharmaceuticals (Ticker: ENTA), holds 70.94K shares in Xencor (Ticker: XNCR).
Profitable Transactions
3 out of 6 Profitable Transactions
Average Return
-33.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Bruce Carter holds in companies
Most Profitable Insider Trade
Stock:
Regulus
(RGLS)
(RGLS)
Rating:Informative Sell
Date:Apr 14, 2015 - Apr 14, 2016
Return:+52.60%
The most profitable trade made by Bruce Carter
Bruce Carter's Trading History
Enanta Pharmaceuticals
Mar 22, 2022
Director
Uninformative Buy
153.48K
$0.00
Mirati Therapeutics
Jan 23, 2024
―
Uninformative Sell
―
$0.00
Regulus
Apr 14, 2015
―
Informative Sell
353.00K
$0.00
Xencor
Jun 16, 2017
Director
Informative Sell
412.20K
$791.74K
Novelion Therapeutics
May 15, 2009
―
Informative Buy
41.40K
$14.04K
List of latest transactions for each holding click on a transaction to see Bruce Carter's performance on stock
You May Also Like
Bruce Carter insider profile FAQ
What is the percentage of profitable transactions made by Bruce Carter?
The percentage of profitable transactions made by Bruce Carter is 50%.
What is the average return per transaction made by Bruce Carter?
The average return per transaction made by Bruce Carter is -33.30%.
What stocks does Bruce Carter hold?
Bruce Carter holds: ENTA, MRTX, RGLS, XNCR, NVLNF stocks.
What was Bruce Carter’s latest transaction?
Bruce Carter latest transaction was an Uninformative Sell of ―.
What was Bruce Carter's most profitable transaction?
Bruce Carter’s most profitable transaction was an Informative Sell of RGLS stock on April 14, 2015. The return on the trade was 52.60%.
What is Bruce Carter's role in Enanta Pharmaceuticals?
Bruce Carter's role in Enanta Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.